Parsaclisib hydrochloride is a novel small molecule inhibitor of PI3Kδ, which is an enzyme that plays an important role in the activation and proliferation of immune cells. The medication is being investigated as a potential treatment for various autoimmune diseases, including lymphoma and multiple sclerosis. It was developed by Incyte Corporation and is currently undergoing clinical trials.
Chemical Name:
The chemical name of Parsaclisib hydrochloride is (S)-6-(8-chloro-1-methyl-2,3-dihydroimidazo[1,2-c]quinazolin-2-ylamino)-3,4-dihydroisoquinolin-1(2H)-ol hydrochloride.
Molecular Formula:
The molecular formula of Parsaclisib hydrochloride is C23H23Cl2N5O•HCl.
Formula Weight:
The formula weight of Parsaclisib hydrochloride is 498.83 g/mol.
CAS No:
The CAS No for Parsaclisib hydrochloride is 1995889-48-9.
Top ten Keywords from Google and Synonyms:
Health benefits of this Product:
Parsaclisib hydrochloride is being investigated as a potential treatment for various autoimmune diseases, including lymphoma, multiple sclerosis, and rheumatoid arthritis. The medication works by inhibiting the activity of PI3Kδ, which is involved in the activation and proliferation of immune cells.
Potential Effects:
By inhibiting PI3Kδ, Parsaclisib hydrochloride can help reduce the activity of immune cells and inflammation associated with autoimmune diseases. This, in turn, may help alleviate symptoms and slow down the progression of the disease. Preliminary studies have shown promise in the treatment of lymphoma and multiple sclerosis.
Product Mechanism:
Parsaclisib hydrochloride works by inhibiting the activity of PI3Kδ, an enzyme that plays an important role in the activation and proliferation of immune cells. By inhibiting this enzyme, Parsaclisib hydrochloride can help reduce the activity of immune cells and the inflammation associated with autoimmune diseases.
Safety:
The safety of Parsaclisib hydrochloride is still being studied. However, preliminary studies have shown that the medication is generally safe and well-tolerated. It is important to consult with your healthcare provider before starting Parsaclisib hydrochloride to determine if it is right for you.
Side Effects:
Common side effects of Parsaclisib hydrochloride may include nausea, diarrhea, and fatigue. More serious side effects, although rare, may include infections and an increased risk of blood clots.
Dosing Information:
The dosing of Parsaclisib hydrochloride may vary depending on the patient's condition, age, and other factors. It is important to follow the prescribed dosage and instructions provided by your healthcare provider.
Conclusion:
Parsaclisib hydrochloride is a promising medication in the treatment of various autoimmune diseases, including lymphoma, multiple sclerosis, and rheumatoid arthritis. It works by inhibiting the activity of PI3Kδ, which is involved in the activation and proliferation of immune cells. While still being studied, preliminary results have shown that the medication is generally safe and well-tolerated. It is important to consult with your healthcare provider before starting Parsaclisib hydrochloride to determine if it is right for you
